Research Center: Medical University of South Carolina
Location: Roper Medical Office Building, 125 Doughty St, Suite 190
Lead Doctors: Drs. Aimee McRae-Clark & Kevin Gray
IRB Committee: This material has been reviewed and approved by MUSC Institutional Review Board

Background

Cannabis is the most widely used illicit substance in the United States and globally. After alcohol, it has the highest rate of dependence or abuse among all drugs. Despite cannabis use disorder (CUD) being an increasingly recognized problem, there currently are no FDA-approved or clinically accepted medication treatments.

MUSC is conducting research studies for people who are interested in quitting or reducing their use of marijuana. These studies will explore if investigational medications can help marijuana users reduce their use. Participation is paid and confidential.

These studies seek men and women who currently use marijuana regularly and are interested in quitting or reducing their use. Participants are required to attend weekly research site visits over approximately 15 weeks and will be paid for their time.

Why Participate?

• You may be helping to improve treatment for Cannabis Use Disorder.
• You will be helping to advance medical research.
• You may be able to reduce your marijuana use.
• You will be compensated up to $1,210 for your time and effort.

Your Rights

• If you decide to participate in a study and later feel that you no longer wish to be part of it, you may withdraw at any time.
• Your records relating to your study participation and any other information received will be kept strictly confidential, except as required by law.
• Qualified health professionals will monitor your health as it relates to your study participation.

Who Can Participate?

• Men and women aged 18 or older 
• Currently using marijuana regularly and are interested in quitting or reducing their use
• Able to attend study visits once a week for approximately 15 weeks, some visits may be conducted virtually

Please note:

Due to the current situation with the COVID-19 pandemic, the study team would like to point out the following:

• The research site does not treat COVID-19 patients and/or suspected COVID-19 patients.
• The waiting area of the research site is spacious enough that participants will not be within close proximity to each other.
• Hand sanitizers are available at the research site.
• The research staff adheres to strict hygienic practices as well as other safety measures to prevent the spread of COVID-19. 
• Any staff suspected to have COVID-19, or has come into contact with someone who has COVID-19, will automatically undergo a voluntary quarantine for 14 days.
• Masks are required for anyone entering the site. If you do not have a mask, one will be provided to you.

Please note that all the information you provide in this study will be kept with strict confidence, and shared only with the study team conducting the study.